Publicaciones (62) Publicaciones de OLGA MARÍA CRUZ LÓPEZ

2023

  1. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect

    European Journal of Medicinal Chemistry, Vol. 258

  2. Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme

    Purinergic Signalling

2022

  1. Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles

    Pharmaceutics, Vol. 14, Núm. 4

2021

  1. Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 1553-1563

  2. Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: Preclinical evaluation in glioblastoma

    Nanomedicine, Vol. 16, Núm. 23, pp. 2095-2115

  3. Effect of covid-19 on the performance indicators and satisfaction rate in the degree in pharmacy of the university of granada

    EduLearn 21 Proceedings: 13th International Conference on Education and New Learning Technologies Online Conference. 5-6 July, 2021.

  4. New insights into cytotoxic mechanisms of bozepinib against glioblastoma

    European Journal of Pharmaceutical Sciences, Vol. 162

  5. Tutorial action and orientation for university students during the covid-19 pandemic at the faculty of pharmacy of the university of granada

    EduLearn 21 Proceedings: 13th International Conference on Education and New Learning Technologies Online Conference. 5-6 July, 2021.

2020

  1. Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells

    Translational Research in Cancer (IntechOpen)

  2. Evaluation of indicators of academic performance and labor insertion of graduates for degree in pharmacy: Making progress towards a quality future

    EDULEARN20 Proceedings: 12th International Conference on Education and New Learning TechnologiesOnline Conference. 6-7 July, 2020. (IATED Academy), pp. 3356-3362

2019

  1. Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity

    ACS Omega, Vol. 4, Núm. 25, pp. 21620-21626

2018

  1. The teaching team of experienced and beginner professors contributes to the continuous improvement of the teaching in the University of Granada

    Edulearn 18. 10th International Conference on Education and New Learning Technology: (Palma, 2nd-4th of July, 2018). Conference proceedings

2017

  1. 1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds

    Future Medicinal Chemistry, Vol. 9, Núm. 11, pp. 1129-1140

  2. Relationship between HMF intake and SMF formation in vivo: An animal and human study

    Molecular Nutrition and Food Research, Vol. 61, Núm. 3

  3. Synthesis of 1,4-benzoxathiin-9H-purine derivatives as antiproliferative agents

    Targets in Heterocyclic Systems, Vol. 21, pp. 372-388

2015

  1. Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study

    European Journal of Medicinal Chemistry, Vol. 101, pp. 185-204

  2. Titulación conjunta de grado en nutrición humana y dietética y ciencia y tecnología de los alimentos (PID 12-132)

    Innovación docente y buenas prácticas en la Universidad de Granada. (Editorial Universidad de Granada), pp. 324-337

2014

  1. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound

    Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606

  2. Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5- substituted thiophene derivatives as allosteric enhancers of the A1 adenosine receptor

    Bioorganic and Medicinal Chemistry, Vol. 22, Núm. 1, pp. 148-166

  3. Synthesis and biological evaluation of novel allosteric enhancers of the A1adenosine receptor based on 2-amino-3-(4′-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene

    Journal of Medicinal Chemistry, Vol. 57, Núm. 18, pp. 7673-7686